文献速递临床试验与 GCP流行病学与生物统计医学人工智能与信息学

路径驱动电子健康整合照护模型用于中国社区高血压管理有效性的随机对照试验研究方案

Effectiveness of a pathway-driven eHealth-based integrated care model (PEICM) for community-based hypertension management in China: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-01-22

本研究为中国社区高血压管理设计了一项为期1年、非盲、优势性、两平行组随机对照试验,计划招募402例高血压患者按1:1随机分配。干预组使用基于「三师共管」模式的路径驱动电子健康整合照护系统,对照组仅使用移动设备测量血压并接受常规随访。主要结局为12个月内收缩压平均变化,旨在评估该模型对高血压控制的效果。

要点

  • 干预组接受基于「三师共管」模式的路径驱动电子健康整合照护,包含9项任务的协调照护路径。
  • 主要结局为12个月内收缩压平均变化,次要结局包括舒张压、生化指标、生活方式、自我管理依从性等。
  • 试验为1年非盲优势性两平行组设计,402例患者按1:1随机,随访节点为入组、6个月和12个月。

核心结论

  • 该研究旨在验证基于「三师共管」模式的路径驱动电子健康整合照护模型能否改善中国社区高血压控制。
  • 若模型成功,将有助于改进现有社区高血压管理流程并使更多血压未控制患者获益。

研究设计与样本

  • 设计为1年、非盲、优势性、两平行组随机对照试验,计划招募402例符合入组标准的高血压患者并按1:1随机分配。
  • 所有参与者均获得移动设备用于自我管理,该设备为远程医疗系统的一部分。
  • 对照组仅使用设备测量血压并按指南接受照护提供者的常规随访;干预组获得系统完整权限并接受基于所提模型的干预。
  • 干预模型为精心设计的协调照护路径,由9项任务组成。
  • 结局主要在入组时、6个月和12个月三个时间点测量。

关键数值与推荐

  • 主要结局为12个月内收缩压平均变化。
  • 次要结局包括舒张压变化、高血压相关生化指标、生活方式、自我管理依从性、高血压知晓率及照护提供者工作效率。

临床怎么用

  • 干预组通过远程医疗系统完整权限接受路径驱动的整合照护,包含9项协调任务。
  • 对照组仅使用移动设备测量血压并接受基于指南的常规随访。
  • 结局评估覆盖入组、6个月和12个月三个时间点,主要关注收缩压平均变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of hypertension is high and increasing in China in recent years. The treatment and control of hypertension calls for long-term management beyond hospital, which is hard to implement in traditional care settings. Integrated care combined with information technology can promote high-quality healthcare services across the life-course. However, few studies have applied a customized integrated care model in community-based hypertension management in China, catering to the emerging "three-manager" mode. This study aims to identify the effectiveness of a pathway-driven eHealth-based integrated model that implemented as a full-featured telehealth system to facilitate standardized management of hypertension in China. METHODS: The trial has been designed as a 1-year, non-blinded superiority trial with two parallel groups. A total of 402 hypertensive patients who meet the eligibility criteria will be recruited and randomized with a 1:1 allocation. All the participants will receive a mobile device for self-management, which is a part of our telehealth system. Participants in the control group will only use the device for BP measurement and receive regular follow-ups from care providers according to the guidelines. Participants in the intervention group will gain full access to the system and receive intervention based on the proposed model (a well-designed coordinated care pathway consisting of 9 tasks). Outcomes will be measured mainly on three occasions (at inclusion, at 6 months, and at 12 months). The primary outcome is mean change in systolic blood pressure over a 12-month period. Secondary outcomes include changes in diastolic blood pressure, biochemical indexes related to hypertension, lifestyles, self-management adherence, and hypertension awareness, as well as work efficiency of care providers. DISCUSSION: This study aims to investigate whether a pathway-driven eHealth-based integrated care model based on the "three-manager" mode will improve hypertension control in China. Success of the model would help improve the quality of present community-based management procedures and benefit more patients with uncontrolled hypertension. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900027645 . Registered on November 22, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang Z, Li C, Huang W, et al. Effectiveness of a pathway-driven eHealth-based integrated care model (PEICM) for community-based hypertension management in China: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33482896. doi:10.1186/s13063-021-05020-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。